Article Text
Electronic pages
Correspondence
Does MOVES move the needle?
Statistics from Altmetric.com
Osteoarthritis (OA) of the knee is a common and vexing condition. Additional safe and effective modalities to treat this chronic condition are badly needed.
The article by Hochberg et al1 summarises the findings from the Multicentre Osteoarthritis interVEntion trial with SYSADOA (MOVES) study and concludes that the combination of glucosamine and chondroitin has equal efficacy to celecoxib, based on a 6-month, non-inferiority design using the change in the Western Ontario and McMaster osteoarthritis index (WOMAC) score as the assessment. Indeed, the combination …
Linked Articles
- Electronic pages